CADTH calls for patient input on a new submission from Celopharma for Mifegymiso

CADTH

18 January 2016 - CADTH has received notice of a pending submission from Celopharma for Mifegymiso (mifepristone with misoprostol) for the medical termination of pregnancy (gestational age up to 49 days).

For more details, go to: https://www.cadth.ca/mifepristone-and-misoprostol

Michael Wonder

Posted by:

Michael Wonder